July 22, 2022
A key health ministry advisory committee will discuss whether to recommend approval for a pediatric indication of Ono Pharmaceutical’s tachyarrhythmia drug Onoact (landiolol) and other label expansions at its meeting on August 4. The Pharmaceutical Affairs and Food Sanitation Council’s...read more